your GLP-1 and GIPR receptor sensitivity varies based on genetic variants like GLP1R rs6923761 and GIPR rs1800437
This approach (which we've refined over years) delivers real results in terms of both safety and experimental accuracy
Jantrapirom S, Nimlamool W, Chattipakorn N, Chattipakorn S, Temviriyanukul P, Inthachat W, Govitrapong P, Potikanond S (2020) Liraglutide suppresses tau hyperphosphorylation, amyloid beta accumulation through regulating neuronal insulin signaling and BACE-1 activity
Estefana Zapata-Pavas, Jon Ande Science Advances .2025;[Epub] CrossRef Association of Diet Quality, Dietary Acid Load, and Dietary Antioxidant Index With Cardiometabolic and NAFLD Risk Factors Among Patients With Metabolic Syndrome: A CrossSectional Study Bijan Ghobadian, Seyedeh Atiye Shahrokhi, Saman Rezaei Talabon, Vahid Notash, Fatemeh Maleki Sedgi, Mehran Rahimlou Food Science & Nutrition .2025;[Epub] CrossRef Quantitative Approaches to Accelerate MASH Drug Discovery and Development Yasmeen Abouelhassan, Shailendra Tallapaka, Ramin Mehrani, Scott Q
However, due to safety or efficacy concerns about anti-obesity treatments, many of the existing medications have limited clinical use
To view or add a comment, sign in Cyclodextrins in action: Cyclodextrin Complexes for Clinical Translatability Do you know the name of Nicholas Bodor